Radiopharm Theranostics announced the appointment of Mr. Vittorio Puppo to the newly created role of Chief Operating Officer (COO), based in New York City. Mr. Puppo brings 30 years of experience in the pharmaceuticals and medical devices industry, having held positions of increased responsibilities in large and mid-cap companies. Mr. Puppo has worked extensively in Europe and the US, and will bring to Radiopharm a broad international perspective and deep knowledge in the radiopharmaceutical sector.

Mr. Puppo's most recent position was as Chief Marketing Officer at Italy-based Bracco Imaging. Prior to that, he successfully ran the Bracco North American operations. Before joining Bracco, Mr. Puppo managed businesses in Europe and Asia for Accuray, Covidien and Mallinckrodt, leading each of his teams to strong results above company expectations.

Earlier in his career, he also worked for Amersham in various leadership roles. Mr. Puppo also served as board member of Life Sciences Capital. He also assisted several start-ups in diagnostics and therapeutics.

Mr. Puppo graduated in Finance at Turin University, earned an MBA at the Bocconi University in Milan, Italy with subsequent education at the Insead and IMD.